inflammation

A unique collection of 5293 anti-inflammation compounds effective for high throughput screening and high content screening.

A unique collection of 210 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;

A unique collection of 89 chemokines or chemokine receptors targeted compounds for high throughput and high content screening;

A unique collection of 223 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2850 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of 861 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;

A unique collection of 631 nuclear receptor signaling targeted compounds for high throughput and high content screening;

A unique collection of 569 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 530 JAK/STAT signaling targeted compounds for high throughput and high content screening;

A unique collection of 1120 compounds targeting NF-κB signaling for high throughput screening and high content screening;

609 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.

A unique collection of 1120 bioactive small molecules with neuroprotective relevance for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 857 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.

1163 compounds associated with depression that can be used for high-throughput and high-content screening

A unique collection of 540 gut microbial metabolites which can be used for HTS and HCS;

A unique collection of 3064 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 536 flavonoids can be used for high throughput and high content screening;

A unique collection of 719 natural terpenes and terpenoids can be used for high throughput and high content screening;

A collection of 1321 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study;

A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1080 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa

A unique collection of 4880 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);

A collection of 234 wine components, suitable for high-throughput and high-content screening.